FDA Documents of Raritan Pharmaceuticals, Inc.
Raritan Pharmaceuticals, Inc. is an organization that has been audited by the FDA 10 times between 2003 and 2018 across all 1 sites.
Documents
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2018
Out-of-stock
Issued on: Jan 8, 2018
Human Drug Form 483
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2016
Out-of-stock
Issued on: Oct 20, 2016
Human Drug Form 483
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2016
Out-of-stock
Issued on: Apr 14, 2016
Human Drug Form 483
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2012
Out-of-stock
Issued on: Sep 19, 2012
Human Drug Form 483
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2012
Out-of-stock
Issued on: Aug 21, 2012
Human Drug Form 483
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2007
Out-of-stock
Issued on: Jan 22, 2007
Human Drug Form 483
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2005
Out-of-stock
Issued on: May 1, 2005
Human Drug Form 483
FDA Investigators(14)
- Guerlain Ulysse, FDA Investigator
- James R. Birkenstamm, FDA Investigator
- Esteban Beltran, FDA Investigator
- Barbara J. Wilimczyk-Macri, FDA Investigator
- Gobiga Vanniyasingam, FDA Investigator
- Frederick Razzaghi, FDA Investigator
- Nicholas A. Violand, FDA Investigator
- Maria Estrella, FDA Investigator
- Anna M. Brannen, FDA Investigator
- Meredith L. Sheridan, FDA Investigator
- Addam S. Reynolds, FDA Investigator
- Daniel J. Grabicki, FDA Investigator
- Kristy A. Zielny, FDA Investigator
- Ernest Bizjak, FDA Investigator